Patients with MTHFR and methylation issues require a unique approach. The standard products on the
market may not be suitable for those with specific issues and therefore a more targeted programme is
required.
The ability to split your B vitamins is desirable as each patient will have a different need and this allows you
to tailor to the individual patient.
What is methylation?
Methylation or one carbon metabolism is a network of interrelated biochemical pathways for reduction or
oxidation and transfer to other compounds. This allows the transfer of a methyl group (one carbon and
three hydrogen atoms) onto amino acids, proteins, enzymes and DNA in every cell and tissue of the body.
This regulates healing, produces energy, genetic expression of DNA, synthesises neurotransmitters, liver
detoxification, immunity and hormonal clearance. So disturbances in this methylation pathway can have
significant and widespread effects on many body systems.
The key pathways are the folate pathway (of which the MTHFR gene is a crucial final step), the methionine
pathway which plays a major role in methyl group metabolism as it allows the recycling of homocysteine
back to methionine and elimination via the CBS (Cystathione beta synthase pathway). The methionine
synthase enzyme contains a cobalamin cofactor 2 which ensures that with the help of Vitamin B12 the
methyl group is transferred to homocysteine. Methionine, which is regenerated from homocysteine is then
converted to S-adenosylmethionine (AdoMET). AdoMet then donates the methyl group it obtained from 5-
MTHF to over 80 biological methylation reactions, including the methylation of DNA, RNA, proteins, lipids
and lipoproteins. The key methyltransferases are the enzyme groups that benefit from this donation of
methyl’s by AdoMET.
What is MTHFR?
MTHFR is a gene, which produces the MTHFR (methylenetetrahydrofolate reductase) enzyme and is
considered a key enzyme in one-carbon metabolism, because it catalyses the irreversible conversion of
5,10-methylene THF to 5-methyl tetrahydrofolate.1 5-MTHF is our active folate that is then used in the
methylation cycle.
Folate Metabolism
http://www.aacc.org/publications/cln/2011/january/Pages/FolateMetabolismFigure.aspx
What happens if MTHFR activity is reduced?
1. 5-MTHF levels go down 2. Transmethylation cycle slows 3. All tissues except liver and kidney show effects of decreased methylation which leads to:
- Decreased neurotransmitter production - Deficiency in glutathione
4. BHMT becomes depleted in choline which causes:
homocysteine levels to rise
methylation in the liver and kidneys decrease
phosphatidylcholine production drops causing cell membrane and myelin instability
This may then have affects for the following conditions:
Diabetes
Cancer
Pulmonary embolisms
Cleft palate
Spina Bifida
Autism
Parkinson’s Disease
Neural tube defects
Cardiovascular disease – atherosclerosis, elevated cholesterol, hypertension, fat metabolism issues
Immune deficiency
ADD/ADHD
MS
Alzheimer’s
Chemical sensitivity
Congenital Heart defects
Fibromyalgia
Chronic fatigue syndrome
Depression
Alcoholism
Addictive behaviours
Insomnia
Downs syndrome
Autism
Chronic viral infection
Thyroid dysfunction
Neuropathy
Recurrent miscarriage
Infertility
Anxiety
Schizophrenia
Bipolar
Allergies
References
1. Selhub.J Homocysteine metabolism. Annu.Rev.Nutr. 19,217,1999
2. Weissbach. H and Taylor RT. Roles of Vitamin B12 and folic acid in methionine synthesis. Vitam. Horm. 28, 415, 1970.
3.Robinson K, Mayer EL, et al. Hyperhomocysteinemia and low pyridoxal phosphate: common and independent reversible risk
factors for coronary artery disease. Circulation. 1995; 92:2825-2830.
4. Homocysteine and Risk of Ischemic Heart Disease and Stroke A Meta-analysis
Homocysteine Studies Collaboration. JAMA. 2002;288(16):2015-2022. doi:10.1001/jama.288.16.20
5. Tungtrongchitr R, Pongpaew P, Prayurahong B, et al: Vitamin B12, folic acid and haematological status of 132 Thai vegetarians.
Int J Vitam Nutr Res 1993; 63:201-207
Starter B & Methylation Support
Specific Indication: Step 1 in methylation support. Initial support for people with the MTHFR gene
mutation to aid, assist in or help support as a cofactor for key enzymes in the methylation cycle (Figure 1).
Pharmaceutical Effects: Starter B contains six B vitamins without Vitamin B12 or folate.
Clinical Benefits: The B vitamins all act as cofactors in the methylation cycle to support critical enzymes
integral to the pathway.
Thiamin (B1) and Pyridoxine (B6) are confirmed by human clinical trials to work together to cause a
decrease in DNA glycation. 1-3Human studies show that the effect of Thiamin decreasing DNA glycation
results in higher levels of methylation.2,3
Riboflavin (B2) acts as a cofactor for folate and so increases methylation. It is the limiting nutrient for
pyridoxine folate and B12 metabolism.2,3,4 It can also assist niacin in reducing excessive DNA methylation.2
It is the cofactor for the MTHFR gene.
Niacin (nicotinamide, B3) and its derivative nicotinamide are dietary precursors of nicotinamide adenine
dinucleotide (NAD). NAD functions in oxidation-reduction (redox) reactions and non-redox reactions. 11
NAD is an important cofactor for MTRR (methionine synthase reductase) enzyme.
http://lpi.oregonstate.edu/mic/vitamins/vitamin-B6
Figure 1. B vitamins & step 1 in methylation support & one-carbon metabolism.
Pantothenic acid (B5) is confirmed by human clinical trials to improve the nutritional and metabolic status
of the genome including DNA methylation,16,17 particularly for mental health in adults and psychology in
children. 18,19,20
Pyridoxine (B6) is confirmed by human clinical trials to increase DNA methylation levels and work together
with riboflavin, folate, and B12. 21,22Deficiency of Pyridoxine in animals results in reduction of DNA
methylation. 23,24 B6 is an important cofactor for the CBS pathway.
Biotin (B7) is confirmed by human clinical trials to be related to folate in its DNA methylation functions16,25.
It works with other vitamins, such as pantothenic acid, riboflavin, niacin, pyridoxine, folate and B12, to play
essential roles in maintaining mitochondrial functions including DNA methylation.2
All doses are safe according to the Australian RDI and the U. S. DRI.
References
1Polizzi FC, Andican G, Çetin E, Civelek S, Yumuk V, Burçak G. Increased DNA-glycation in type 2 diabetic patients: the effect of thiamine and pyridoxine therapy. Experimental and clinical endocrinology & diabetes, June 2012, 120(6), 329-34. PubMed PMID: 22231921
2 Schupp N, Dette EM, Schmid U, Bahner U, Winkler M, Heidland A, Stopper H. Benfotiamine reduces genomic damage in peripheral lymphocytes of hemodialysis patients. Naunyn-Schmiedeberg's archives of pharmacology, September 2008, 378(3), 283-91. PubMed PMID: 18509620
3 Schupp N, Schmid U, Heidland A, Stopper H. New approaches for the treatment of genomic damage in end-stage renal disease. Journal of renal nutrition, January 2008, 18(1), 127-33. PubMed PMID: 18089459
4 Maslinska D, Laure-Kamionowska M, Maslinski S. Methyl-CpG binding protein 2, receptors of innate immunity and receptor for advanced glycation end-products in human viral meningoencephalitis. Folia neuropathologica, 2014, 52(4), 428-35. PubMed PMID: 25574748
5 Lu W, Li J, Ren M, Zeng Y, Zhu P, Lin L, Lin D, Hao S, Gao Q, Liang J, Yan L, Yang C. Role of the mevalonate pathway in specific CpG site demethylation on AGEs-induced MMP9 expression and activation in keratinocytes. Molecular and cellular endocrinology, August 2015, 15(411), 121-129. PubMed PMID: 25916956
6 Powers HJ, Hill MH, Welfare M, Spiers A, Bal W, Russell J, Duckworth Y, Gibney E, Williams EA, Mathers JC. Responses of biomarkers of folate and riboflavin status to folate and riboflavin supplementation in healthy and colorectal polyp patients (the FAB2 Study). Cancer epidemiology, biomarkers & prevention, October 2007, 16(10), 2128-35. PubMed PMID: 17932361
7 Figueiredo JC, Levine AJ, Grau MV, Midttun O, Ueland PM, Ahnen DJ, Barry EL, Tsang S, Munroe D, Ali I, Haile RW, Sandler RS, Baron JA. Vitamins B2, B6, and B12 and risk of new colorectal adenomas in a randomized trial of aspirin use and folic acid supplementation. Cancer epidemiology, biomarkers & prevention, August 2008, 17(8), 2136-45. PubMed PMID: 18708408
8Nedrebø BG, Hustad S, Schneede J, Ueland PM, Vollset SE, Holm PI, Aanderud S, Lien EA. Homocysteine and its relation to B-vitamins in Graves' disease before and after treatment: effect modification by smoking. Journal of internal medicine, November 2003, 254(5), 504-12. PubMed PMID: 14535973
9Madigan SM, Tracey F, McNulty H, Eaton-Evans J, Coulter J, McCartney H, Strain JJ. Riboflavin and vitamin B-6 intakes and status and biochemical response to riboflavin supplementation in free-living elderly people. American journal of clinical nutrition, August 1998, 68(2), 389-95. PubMed PMID: 9701198
10Premkumar VG, Yuvaraj S, Shanthi P, Sachdanandam P. Co-enzyme Q10, riboflavin and niacin supplementation on alteration of DNA repair enzyme and DNA methylation in breast cancer patients undergoing tamoxifen therapy. British journal of nutrition, December 2008, 100(6), 1179-82. PubMed PMID: 18377693
11Penberthy WT, Kirkland JB. Niacin. In:Erdman JW, MacDonald I, Zeisel SH, eds. Present Knowledge in Nutrition. 10th ed. Ames: International
Life Sciences Institute;2012:293-306
12Sun WP, Li D, Lun YZ, et al. Excess nicotinamide inhibits methylation-mediated degradation of catecholamines in normotensives and hypertensives. Hypertension Research. 2012 Feb; 35(2): 180-5. PubMed PMID: 21918528.
13Aoyama K, Matsubara K, Okada K, et al. N-methylation ability for azaheterocyclic amines is higher in Parkinson's disease: nicotinamide loading test. Journal of Neural Transmission (Vienna). 2000; 107(8-9): 985-95. PubMed PMID: 11041277.
14Jacob RA, Pianalto FS, Henning SM, Zhang JZ, & Swendseid ME. In vivo methylation capacity is not impaired in healthy men during short-term dietary folate and methyl group restriction. Journal of Nutrition. 1995 Jun; 125(6): 1495-502. PubMed PMID: 7782903.
15Okada K., Matsubara K., Kobayashi S., et al. 275 Abnormal N-methylation of nicotinamide in Parkinson's disease. Neurobiology of Aging, 1996, 17(4), Supplement 1, S69. Retrieved from http://www.neurobiologyofaging.org/article/S0197-4580(96)80277-6/abstract
16Fenech M, Baghurst P, Luderer W, Turner J, Record S, Ceppi M, Bonassi S. Low intake of calcium, folate, nicotinic acid, vitamin E, retinol, beta-carotene and high intake of pantothenic acid, biotin and riboflavin are significantly associated with increased genome instability--results from a dietary intake and micronucleus index survey in South Australia. Carcinogenesis, May 2005, 26(5), 991-9. PubMed PMID: 15705599
17Adams JB, Audhya T, McDonough-Means S, Rubin RA, Quig D, Geis E, Gehn E, Loresto M, Mitchell J, Atwood S, Barnhouse S, Lee W. Effect of a vitamin/mineral supplement on children and adults with autism. BMC Pediatrics, December 2011, 11, 111. PubMed PMID: 22151477
18Herbison CE, Hickling S, Allen KL, O'Sullivan TA, Robinson M, Bremner AP, Huang RC, Beilin LJ, Mori TA, Oddy WH. Low intake of B-vitamins is associated with poor adolescent mental health and behaviour. Preventive Medicine, December 2012, 55(6), 634-638. PubMed PMID: 23010437
19Rucklidge JJ, Harris AL, Shaw IC. Are the amounts of vitamins in commercially available dietary supplement formulations relevant for the management of psychiatric disorders in children? New Zealand Medical Journal, April 2014, 127(1392), 73-85. PubMed PMID: 24806250
20Uchida Y, Ito K, Ohtsuki S, Kubo Y, Suzuki T, Terasaki T. Major involvement of Na(+) -dependent multivitamin transporter (SLC5A6/SMVT) in uptake of biotin and pantothenic acid by human brain capillary endothelial cells. Journal of Neurochemistry, July 2015, 134(1), 97-112. PubMed PMID: 25809983
21Pirouzpanah S, Taleban FA, Mehdipour P, Atri M. Association of folate and other one-carbon related nutrients with hypermethylation status and expression of RARB, BRCA1, and RASSF1A genes in breast cancer patients. Journal of molecular medicine (Berlin, Germany), August 2015, 93(8), 917-34. PubMed PMID: 25805039
22Maruti SS, Ulrich CM, White E. Folate and one-carbon metabolism nutrients from supplements and diet in relation to breast cancer risk. American journal of clinical nutrition, February 2009, 89(2), 624-33. PubMed PMID: 19116331
23Martinez M, Cuskelly GJ, Williamson J, Toth JP, Gregory JF 3rd. Vitamin B-6 deficiency in rats reduces hepatic serine hydroxymethyltransferase and cystathionine beta-synthase activities and rates of in vivo protein turnover, homocysteine remethylation and transsulfuration. Journal of Nutrition, May 2000, 130(5), 1115-23. PubMed PMID: 10801907
24Eloranta TO, Kajander EO, Raina AM. A new method for the assay of tissue. S-adenosylhomocysteine and S-adenosylmethione. Effect of pyridoxine deficiency on the metabolism of S-adenosylhomocysteine, S-adenosylmethionine and polyamines in rat liver. Biochemical journal, November 1976, 160(2), 287-94. PubMed PMID: 1008858
25Xue J, Zempleni J. Epigenetic synergies between biotin and folate in the regulation of pro-inflammatory cytokines and repeats. Scandinavian journal of immunolog, November 2013, 78(5), 419-25. PubMed PMID: 24007195
26Depeint F, Bruce WR, Shangari N, Mehta R, O'Brien PJ. Mitochondrial function and toxicity: role of the B vitamin family on mitochondrial energy metabolism. Chemico-biological interactions, October 2006, 163(1-2), 94-112. PubMed PMID: 16765926
Hydroxocobalamin & Methylation Support
Specific Indication: Step 2 in methylation support.
Pharmaceutical Effects: Precursor to Active B12's – methylcobalamin & adenosylcobalamin
Clinical Benefits:
Provides a stable and naturally occurring form of Vitamin B12 Converts to both methylcobalamin and adenosylcobalamin. May support the methylation cycle without causing side effects
Particularly important for those with adenosylcobalamin SNP’s – MMAB, MUT
Chewable form for better absorption Easily taken by children
Hydroxocobalamin is a naturally occurring form of Vitamin B12. It is a precursor molecule for
methylcobalamin and adenosylcobalamin. In the human body, hydroxocobalamin is converted to
cobalamin that is readily absorbed in the gut. One of the important functions of hydroxocobalamin in the
body is conversion of homocysteine into the essential amino acid methionine2 . It is also required for
proper functioning in of the nervous system and energy generation for cellular activities.
Role of Hydroxocobalamin as a Cofactor
The cobalamin or Vitamin B12 is one of the essential nutrients required for integral functions. It usually
works with folate to carry out chromosomal replication and DNA synthesis in myeloid cells and bone
marrow. Similarly, its role is also well established in maintaining the integrity and stability of the myelin
sheath on nerve cells4 . Vitamin B12 deficiency directly impacts the nerve cells impairing cognitive and
psychological capabilities. It also coverts methymalonic acid to another compound namely succinate.
Succinate further helps in linking carbohydrate and lipid metabolism in the body for energy generation5. In
the cytosol, due to methylation processes hydroxocobalamin is converted into methylcobalamin. But in
many instances, the reduction reaction in the presence of ATP results in the generation of
adenosylcobalamin.
Prescription as a Therapeutic Agent
Hydroxocobalamin has shown high affinity for the cyanide molecule and reacts with any cyanide molecules
by pulling them out of the mitochondria. The reaction of cyanide and hydroxocobalamin results in
production of cyanocobalamin which can easily be excreted through urine resulting in detoxification .
One very important function of hydroxocobalamin is its role as a scavenger of nitric oxide and its
derivatives. Many studies have indicated that hydroxocobalamin is in fact the only form of Vitamin B12
that reduces the cellular toxicity of nitric oxide by neutralizing its damage and toxicity of cellular functions.
The core atom of hydroxocobalamin, Cobalt (III) interacts with nitric oxide neutralising the toxicity.
Nitric acid functions as a muscle regulator but due to a number of circumstances increases in levels leads
to discomfort and swelling in the neural cells. In one study, the utilization of hydroxocobalamin was seen
to significantly reduce the occurrence, frequency and severity of migraines .
References:
1Hall CA, Begley JA, Green-Colligan PD. The availability of therapeutic hydroxocobalamin to cells. Blood. 1984 Feb; 63(2): 335-41. PMID: 6692038.
2Andrès E, Fothergill H, Mecili M. Efficacy of oral cobalamin (vitamin B12) therapy. Expert opinion on pharmacotherapy. 2010 Feb; 11(2): 249-56. PMID:
20088746.
3Carrillo-Carrasco N, Sloan J, Valle D, Hamosh A, Venditti CP. Hydroxocobalamin dose escalation improves metabolic control in cblC. Journal of inherited
metabolic disease. 2009 Oct; 32(6): 728-31. PMCID: PMC3479241.
4Hamel J. A review of acute cyanide poisoning with a treatment update. Critical care nurse. 2011 Feb; 31(1): 72-82. PMID: 21285466.5Seetharam B, Yammani RR.
Cobalamin transport proteins and their cell-surface receptors. Expert reviews in molecular medicine. 2003 Jun; 5(18): 1-18. PMID: 14585166.
6Andrès E, Fothergill H, Mecili M. Efficacy of oral cobalamin (vitamin B12) therapy. Expert opinion on pharmacotherapy. 2010 Feb; 11(2): 249-56. PMID: 20088746. 7Bhattacharya R. Antidotes to cyanide poisoning: present status. Indian Journal of Pharmacology. 2000; 32(2): 94-101. 8Shepherd G, Velez LI. Formulary Forum: Role of Hydroxocobalamin in Acute Cyanide Poisoning. Annals of Pharmacotherapy. 2008 May; 42(5): 661-9. PMID: 18397973. 9Sauer SW, Keim ME. Hydroxocobalamin: improved public health readiness for cyanide disasters. Annals of emergency medicine. 2001 Jun; 37(6): 635-41. PMID: 11385334. 10DesLauriers CA, Burda AM, Wahl M. Hydroxocobalamin as a cyanide antidote. American journal of therapeutics. 2006; 13(2): 161-165. 11Greenberg SS, Xie J, Zatarain JM, Kapusta DR, Miller MJ. Hydroxocobalamin (vitamin B12a) prevents and reverses endotoxin-induced hypotension and mortality in rodents: role of nitric oxide. Journal of Pharmacology and Experimental Therapeutics. 1995 Apr; 273(1): 257-265. PMID: 7714773. 12DesLauriers CA, Burda AM, Wahl M. Hydroxocobalamin as a cyanide antidote. American journal of therapeutics. 2006; 13(2): 161-165.
Methylcobalamin & Methylation Support
Specific Indication: Step 2 in methylation support.
Pharmaceutical Effects: Active B12
Clinical Benefits:
Critical coenzyme required for methylation through methionine Synthase4 Plays an important role in developing cognitive ability by regulating the myelin sheath and basic structure of nerve cells Only cobalamin compound that regulates the sleep wake cycle. Is directly utilised by enzymes that are dependent on Vitamin B12 for their functioning i.e.: methionine synthase.4 Chewable form for better absorption Easily taken by children
Methylcobalamin also referred to as MeB12 and MeCbl is another compound of the cobalamin family. It is
one of the naturally occurring coenzyme forms of cobalamin found in the human body.1-3
Hydroxocobalamin is metabolised into adenosylcobalamin and methylcobalamin. According to estimates,
almost 80% of cobalamin present in body is in the form of methylcobalamin.
Important Functions of Methylcobalamin
Plays an important role in developing cognitive ability by regulating the myelin sheath and basic structure
of nerve cells.
Only cobalamin compound that regulates the sleep wake cycle. It improves the overall quality of sleep and
helps in developing nerve cells by maintaining the circadian rhythms. Due to its deficiency, the sleep wake
cycle is greatly disturbed leading to symptoms such as agitation, anxiety, restlessness and distress.
Methylcobalamin is one of the coenzymes that is directly utilized by enzymes which are dependent on
vitamin B12 for their functioning. Methionine synthase specifically utilises methylcobalamin as a cofactor
in their reactions4
Acetyl-CoA is one of the basic compounds required by a number of organisms to produce complex organic
derivatives for different reactions and pathways. A reduced level of methylcobalamin can prompt subacute
spinal cord degeneration and megaloblastic iron deficiency4.
Analgesic Effect of Methyl Cobalamin
a. Neuropathic Pain in Diabetic Neuropathy
One of the important clinical benefits of methylcobalamin is inhibiting pain connected with diabetic
neuropathy. The neuropathic pain has been described as burning and aching irritation which increases the
sensitivity of the skin7.. The clinical trials have indicated that methylcobalamin may reduce the occurrence
and frequency of neuropathic pain associated with diabetes8. The oral use of methylcobalamin reduces
intensity of pain by improving overall velocity of nerve impulses and conduction. The studies have
observed the reduction in overall pain scale score in neuropathic pain after consumption of methyl
cobalamin. After four weeks of injectable methylcobalamin, 73% reduction in pain symptoms were
observed through Likert-type pain intensity scale. The researchers identified improved sensory and motor
nerve impulses and velocity through consumption of methylcobalamin indicating its significant role as
analgesic9.
b. Neuralgia
The action of methylcobalamin has also been reported to ease pain associated with different neuralgia.
Considerable reduction in pain values was observed in trigeminal neuralgia, facial neuralgia, sub-acute
herpetic neuralgia and glossopharyngeal neuralgia10. Intravenous injection of methylcobalamin greatly
reduces the symptoms of pain in trigeminal neuralgia11. It not only reduces the pain symptoms but may
also improves quality of life13. It may also improve the velocity of nerve conduction thus acting as an
analgesic in many neuropathies8.
References
1 Rossi M, Glusker JP, Randaccio L, Summers MF, Toscano PJ, Marzilli LG. The structure of a B12 coenzyme: methylcobalamin studies by X-ray and NMR methods. Journal of the American Chemical Society. 1985 March; 107(6): 1729-38. 2Xu G, Lv ZW, Feng Y, Tang WZ, Xu GX. A Single‐Center Randomized Controlled Trial of Local Methylcobalamin Injection for Subacute Herpetic Neuralgia. Pain Medicine. 2013 Jun; 14(6): 884-94. PMID: 23566267. 3Okada K, Tanaka H, Temporin K, Okamoto M, Kuroda Y, Moritomo H, Murase T, Yoshikawa, H. Methylcobalamin increases Erk1/2 and Akt activities through the methylation cycle and promotes nerve regeneration in a rat sciatic nerve injury model. ). Experimental neurology. 2010 Apr; 222(2), 191-203. PMID: 20045411. 4Okada K, Tanaka H, Temporin K, Okamoto M, Kuroda Y, Moritomo H, Murase T, Yoshikawa, H. Methylcobalamin increases Erk1/2 and Akt activities through the methylation cycle and promotes nerve regeneration in a rat sciatic nerve injury model. ). Experimental neurology. 2010 Apr; 222(2), 191-203. PMID: 20045411. 5Xu G, Lv ZW, Feng Y, Tang WZ, Xu GX. A Single‐Center Randomized Controlled Trial of Local Methylcobalamin Injection for Subacute Herpetic Neuralgia. Pain Medicine. 2013 Jun; 14(6): 884-94. PMID: 23566267. 6Jensen KP, Ryde, U. Conversion of homocysteine to methionine by methionine synthase: A density functional study. Journal of the American Chemical Society. 2003 Nov; 125(46): 13970-71. PMID: 14611228. 7Li G. [Effect of mecobalamin on diabetic neuropathies. Beijing Methycobal Clinical Trial Collaborative Group]. Zhonghua Nei Ke Za Zhi. 1999 Jan; 38(1): 14-7. PMID: 11798619. 8Devathasan G, Teo WL, Mylvaganam A. Methylcobalamin (CH3-B12; Methycobal) in chronic diabetic neuropathy. A double-blind clinical and electrophysiological study. 1986. 9Dongre YU, Swami OC. Sustained-release pregabalin with methylcobalamin in neuropathic pain: an Indian real-life experience. International Journal General Medicine. 2013 May; 6. 413-7. PMID: 23761981. 10Singh PM, Dehran M, Mohan VK, Trikha A, Kaur M. Analgesic efficacy and safety of medical therapy alone vs. combined medical therapy and extraoral glossopharyngeal nerve block in glossopharyngeal neuralgia. Pain Medicine. 2013 Jan; 14(1): 93-102. PMID: 23279193.
11Xu G, Lv ZW, Feng Y, Tang WZ, Xu GX. A Single‐Center Randomized Controlled Trial of Local Methylcobalamin Injection for Subacute Herpetic Neuralgia. Pain Medicine. 2013 Jun; 14(6): 884-94. PMID: 23566267. 12Singh PM, Dehran M, Mohan VK, Trikha A, Kaur M. Analgesic efficacy and safety of medical therapy alone vs. combined medical therapy and extraoral glossopharyngeal nerve block in glossopharyngeal neuralgia. Pain Medicine. 2013 Jan; 14(1): 93-102. PMID: 23279193. 13Teramoto J. Effects of Methylcobalamin on neuralgia. Neurological Therapeutics. 1984; 1(2): 315. 14Okada K, Tanaka H, Temporin K, Okamoto M, Kuroda Y, Moritomo H, Murase T, Yoshikawa, H. Methylcobalamin increases Erk1/2 and Akt activities through the methylation cycle and promotes nerve regeneration in a rat sciatic nerve injury model. ). Experimental neurology. 2010 Apr; 222(2), 191-203. PMID: 20045411. 15Watanabe T, Kaji R, Oka N, Bara W, Kimura J. Ultra-high dose methylcobalamin promotes nerve regeneration in experimental acrylamide neuropathy. Journal of the neurological sciences. 1994 Apr; 122(2): 140-3. PMID: 8021696. 16Jensen KP, Ryde, U. Conversion of homocysteine to methionine by methionine synthase: A density functional study. Journal of the American Chemical Society.
2003 Nov; 125(46): 13970-71. PMID: 14611228.
Total B (methyl) & Methylation Support
Specific Indication: Step 3 in methylation support. Multi B with active methyl folate and methyl B12
support and assist in methylation reactions (Figure 1).
Pharmaceutical Effects: Total B contains eight B vitamins with methylcobalamin and methyl folate.
Clinical Benefits:
Supports critical enzymes in the methylation cycle Contains Metafolin form of L-5MTHF for superior absorption and stability Low excipients Vegan and vegetarian friendly No corn, soy, gluten, dairy, egg, GMO
Thiamin (B1) and Pyridoxine (B6) are confirmed by human clinical trials to work together to decrease DNA
glycation,1-3 which increases higher levels of methylation.4,5
Riboflavin (B2) enhances the effect of low-dose folate by increasing methylation reactions of other
vitamins such as pyridoxine, folate and B12.6,7,8,9
Niacin (nicotinamide, B3) and its derivative nicotinamide are dietary precursors of nicotinamide adenine
dinucleotide (NAD). NAD functions in oxidation-reduction (redox) reactions and non-redox reactions. 11
NAD is an important cofactor for MTRR (methionine synthase reductase) enzyme.
Pantothenic acid (B5) is confirmed to improve DNA methylation,15,16 particularly for mental health.17,18,19
Pyridoxine (B6) increases DNA methylation levels and works together with riboflavin, folate, and B12.20,21
Deficiency causes reduced DNA methylation.22,23
Biotin (B7) is related to folate in its DNA methylation functions.16,24 It works with other vitamins on
mitochondrial functions and DNA methylation.25
Folate (L-5-MTHF) increases genome and other DNA methylation in healthy patients26-29.
Oral folate will not cause excessive DNA methylation.30 The folate effect of increasing DNA methylation can
reduce homocysteine levels31. 5-MTHF, works faster, more efficient, is safer, crosses the blood brain
barrier and does not mask a Vitamin B12 deficiency.32,34,35
Methylcobalamin (Methyl B12) maintains a desirably high degree of genome DNA methylation.36,37. B12
deficiency can reduce genome DNA methylation in the body up to 2 folds.38-40It works with folate to reduce
homocysteine level.41,42
Metafolin (L (6S)-5-MTHF) is a calcium. As a crystalline type I form it has solid stability, is soluble in water.33
All doses are safe according to the Australian RDI and the U. S. DRI
Figure 1. B vitamins & step 3 in methylation support & one-carbon metabolism.
References
1 Polizzi FC, Andican G, Çetin E, Civelek S, Yumuk V, Burçak G. Increased DNA-glycation in type 2 diabetic patients: the effect of thiamine and pyridoxine therapy. Experimental and clinical endocrinology & diabetes, June 2012, 120(6), 329-34. PubMed PMID: 22231921
2Schupp N, Dette EM, Schmid U, Bahner U, Winkler M, Heidland A, Stopper H. Benfotiamine reduces genomic damage in peripheral lymphocytes of hemodialysis patients. Naunyn-Schmiedeberg's archives of pharmacology, September 2008, 378(3), 283-91. PubMed PMID:18509620
3Schupp N, Schmid U, Heidland A, Stopper H. New approaches for the treatment of genomic damage in end-stage renal disease. Journal of renal nutrition, January 2008, 18(1), 127-33. PubMed PMID:18089459
4Maslinska D, Laure-Kamionowska M, Maslinski S. Methyl-CpG binding protein 2, receptors of innate immunity and receptor for advanced glycation end-products in human viral meningoencephalitis. Folia neuropathologica, 2014, 52(4), 428-35. PubMed PMID:25574748
5Lu W, Li J, Ren M, Zeng Y, Zhu P, Lin L, Lin D, Hao S, Gao Q, Liang J, Yan L, Yang C. Role of the mevalonate pathway in specific CpG site demethylation on AGEs-induced MMP9 expression and activation in keratinocytes. Molecular and cellular endocrinology, August 2015, 15(411), 121-129. PubMed PMID:25916956
6Powers HJ, Hill MH, Welfare M, Spiers A, Bal W, Russell J, Duckworth Y, Gibney E, Williams EA, Mathers JC. Responses of biomarkers of folate and riboflavin status to folate and riboflavin supplementation in healthy and colorectal polyp patients (the FAB2 Study). Cancer epidemiology, biomarkers & prevention, October 2007, 16(10), 2128-35. PubMed PMID:17932361
7Figueiredo JC, Levine AJ, Grau MV, Midttun O, Ueland PM, Ahnen DJ, Barry EL, Tsang S, Munroe D, Ali I, Haile RW, Sandler RS, Baron JA. Vitamins B2, B6, and B12 and risk of new colorectal adenomas in a randomized trial of aspirin use and folic acid supplementation. Cancer epidemiology, biomarkers & prevention, August 2008, 17(8), 2136-45. PubMed PMID: 18708408
8Nedrebø BG, Hustad S, Schneede J, Ueland PM, Vollset SE, Holm PI, Aanderud S, Lien EA. Homocysteine and its relation to B-vitamins in Graves' disease before and after treatment: effect modification by smoking. Journal of internal medicine, November 2003, 254(5), 504-12. PubMed PMID:14535973
9Madigan SM, Tracey F, McNulty H, Eaton-Evans J, Coulter J, McCartney H, Strain JJ. Riboflavin and vitamin B-6 intakes and status and biochemical response to riboflavin supplementation in free-living elderly people. American journal of clinical nutrition, August 1998, 68(2), 389-95. PubMed PMID:9701198
10Tian YJ, Li D, Ma Q, et al. Excess nicotinamide increases plasma serotonin and histamine levels. Sheng Li Xue Bao. 2013 Feb 25;65(1):33-8. PubMed PMID: 23426511.
11Penberthy WT, Kirkland JB. Niacin. In:Erdman JW, MacDonald I, Zeisel SH, eds. Present Knowledge in Nutrition. 10th ed. Ames: International Life Sciences
Institute;2012:293-306
12Aoyama K, Matsubara K, Okada K, et al. N-methylation ability for azaheterocyclic amines is higher in Parkinson's disease: nicotinamide loading test. Journal of Neural Transmission (Vienna). 2000;107(8-9):985-95. PubMed PMID: 11041277.
13Jacob RA, Pianalto FS, Henning SM, Zhang JZ, & Swendseid ME. In vivo methylation capacity is not impaired in healthy men during short-term dietary folate and methyl group restriction. Journal of Nutrition. 1995 Jun; 125(6): 1495-502. PubMed PMID: 7782903.
14Okada K., Matsubara K., Kobayashi S., et al. 275 Abnormal N-methylation of nicotinamide in Parkinson's disease. Neurobiology of Aging, 1996,17(4), Supplement 1, S69.Retrieved from http://www.neurobiologyofaging.org/article/S0197-4580(96)80277-6/abstract
15Fenech M, Baghurst P, Luderer W, Turner J, Record S, Ceppi M, Bonassi S. Low intake of calcium, folate, nicotinic acid, vitamin E, retinol, beta-carotene and high intake of pantothenic acid, biotin and riboflavin are significantly associated with increased genome instability--results from a dietary intake and micronucleus index survey in South Australia. Carcinogenesis, May 2005, 26(5), 991-9. PubMed PMID:15705599
16Adams JB, Audhya T, McDonough-Means S, Rubin RA, Quig D, Geis E, Gehn E, Loresto M, Mitchell J, Atwood S, Barnhouse S, Lee W. Effect of a vitamin/mineral supplement on children and adults with autism. BMC Pediatrics, December 2011, 11, 111. PubMed PMID: 22151477
17Herbison CE, Hickling S, Allen KL, O'Sullivan TA, Robinson M, Bremner AP, Huang RC, Beilin LJ, Mori TA, Oddy WH. Low intake of B-vitamins is associated with poor adolescent mental health and behaviour. Preventive Medicine, December 2012, 55(6), 634-638. PubMed PMID: 23010437
18Rucklidge JJ, Harris AL, Shaw IC. Are the amounts of vitamins in commercially available dietary supplement formulations relevant for the management of psychiatric disorders in children? New Zealand Medical Journal, April 2014, 127(1392), 73-85. PubMed PMID:24806250
19Uchida Y, Ito K, Ohtsuki S, Kubo Y, Suzuki T, Terasaki T. Major involvement of Na(+) -dependent multivitamin transporter (SLC5A6/SMVT) in uptake of biotin and pantothenic acid by human brain capillary endothelial cells. Journal of Neurochemistry, July 2015, 134(1), 97-112. PubMed PMID:25809983
20Pirouzpanah S, Taleban FA, Mehdipour P, Atri M. Association of folate and other one-carbon related nutrients with hypermethylation status and expression of RARB, BRCA1, and RASSF1A genes in breast cancer patients. Journal of molecular medicine (Berlin, Germany), August 2015, 93(8), 917-34. PubMed PMID:25805039
21Maruti SS, Ulrich CM, White E. Folate and one-carbon metabolism nutrients from supplements and diet in relation to breast cancer risk. American journal of clinical nutrition, February 2009, 89(2), 624-33. PubMed PMID:19116331
22Martinez M, Cuskelly GJ, Williamson J, Toth JP, Gregory JF 3rd. Vitamin B-6 deficiency in rats reduces hepatic serine hydroxymethyltransferase and cystathionine beta-synthase activities and rates of in vivo protein turnover, homocysteine remethylation and transsulfuration. Journal of Nutrition, May 2000, 130(5), 1115-23. PubMed PMID:10801907
23Eloranta TO, Kajander EO, Raina AM. A new method for the assay of tissue. S-adenosylhomocysteine and S-adenosylmethione. Effect of pyridoxine deficiency on the metabolism of S-adenosylhomocysteine, S-adenosylmethionine and polyamines in rat liver. Biochemical journal, November 1976, 160(2), 287-94. PubMed PMID: 1008858
24Xue J, Zempleni J. Epigenetic synergies between biotin and folate in the regulation of pro-inflammatory cytokines and repeats. Scandinavian journal of immunolog, November 2013, 78(5), 419-25. PubMed PMID:24007195
25Depeint F, Bruce WR, Shangari N, Mehta R, O'Brien PJ. Mitochondrial function and toxicity: role of the B vitamin family on mitochondrial energy metabolism. Chemico-biological interactions, October 2006, 163(1-2), 94-112. PubMed PMID:16765926
26Crider KS, Quinlivan EP, Berry RJ, Hao L, Li Z, Maneval D, Yang TP, Rasmussen SA, Yang Q, Zhu JH, Hu DJ, Bailey LB. Genomic DNA methylation changes in response to folic acid supplementation in a population-based intervention study among women of reproductive age. PLoS One, 2011, 6(12), e28144. PubMed PMID:22163281
27Pufulete M, Al-Ghnaniem R, Rennie JA, Appleby P, Harris N, Gout S, Emery PW, Sanders TA. Influence of folate status on genomic DNA methylation in colonic mucosa of subjects without colorectal adenoma or cancer. British Journal of Cancer, March 2005, 92(5), 838-42. PubMed PMID:15726099
28Cravo ML, Pinto AG, Chaves P, Cruz JA, Lage P, Nobre Leitão C, Costa Mira F. Effect of folate supplementation on DNA methylation of rectal mucosa in patients with colonic adenomas: correlation with nutrient intake. Clinical nutrition (Edinburgh, Scotland), April 1998, 17(2), 45-9. PubMed PMID:10205316
29Ingrosso D, Cimmino A, Perna AF, Masella L, De Santo NG, De Bonis ML, Vacca M, D'Esposito M, D'Urso M, Galletti P, Zappia V. Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia. Lancet, May 2003, 361(9370), 1693-9. PubMed PMID: 12767735
30Wallace K, Grau MV, Levine AJ, Shen L, Hamdan R, Chen X, Gui J, Haile RW, Barry EL, Ahnen D, McKeown-Eyssen G, Baron JA, Issa JP. Association between folate levels and CpG Island hypermethylation in normal colorectal mucosa. Cancer prevention research (Philadelphia, Pa.), December 2010, 3(12), 1552-64. PubMed PMID:21149331
31Akoglu B, Schrott M, Bolouri H, Jaffari A, Kutschera E, Caspary WF, Faust D. The folic acid metabolite L-5-methyltetrahydrofolate effectively reduces total serum homocysteine level in orthotopic liver transplant recipients: a double-blind placebo-controlled study. European journal of clinical nutrition, June 2008, 62(6), 796-801. PubMed PMID:17522618
32Visentin CE, Masih SP, Plumptre L, Schroder TH, Sohn KJ, Ly A, Lausman AY, Berger H, Croxford R, Lamers Y, Kim YI, O'Connor DL. Low Serum Vitamin B-12 Concentrations Are Prevalent in a Cohort of Pregnant Canadian Women. J Nutr. 2016 May; 146(5): 1035-42. PMID: 27075906
33Wallin, H;Kuznesof, PM. Calcium L-5-Methyltetrahydrofolate (L-5-MTHF-CA). Chemical and Technical Assessment 65th JEFCA.
34Obeid R, Holzgreve W, Pietrzik K. Is 5-methyltetrahydrofolate an alternative to folic acid for the prevention of neural tube defects? J Perinat Med. 2013 Sep 1; 41(5): 469-83. PMID: 23482308
35Knowles L, Morris AA, Walter JH. Treatment with Mefolinate (5-Methyltetrahydrofolate), but Not Folic Acid or Folinic Acid, Leads to Measurable 5-Methyltetrahydrofolate in Cerebrospinal Fluid in Methylenetetrahydrofolate Reductase Deficiency. JIMD Rep. 2016 Feb 23. PMID: 26898294
36Hendren RL, James SJ, Widjaja F, Lawton B, Rosenblatt A, Bent S. Randomized, Placebo-Controlled Trial of Methyl B12 for Children with Autism. Journal of child and adolescent psychopharmacology, February 2016, volume x, issue x, page 1-10. Ahead of print.PubMed PMID: 26889605
37Piyathilake CJ, Macaluso M, Chambers MM, Badiga S, Siddiqui NR, Bell WC, Edberg JC, Partridge EE, Alvarez RD, Johanning GL. Folate and vitamin B12 may play a critical role in lowering the HPV 16 methylation-associated risk of developing higher grades of CIN. Cancer prevention research (Philadelphia, Pa.), November 2014, 7(11), 1128-1137. PubMed PMID:25145486
38Pourié G, Martin N, Bossenmeyer-Pourié C, Akchiche N, Guéant-Rodriguez RM, Geoffroy A, Jeannesson E, El Hajj Chehadeh S, Mimoun K, Brachet P, Koziel V, Alberto JM, Helle D, Debard R, Leininger B, Daval JL, Guéant JL. Folate- and vitamin B12-deficient diet during gestation and lactation alters cerebellar synapsin expression via impaired influence of estrogen nuclear receptor α. FASEB Journal, September 2015, 29(9), 3713-3725. PubMed PMID:26018677
39Adaikalakoteswari A, Finer S, Voyias PD, McCarthy CM, Vatish M, Moore J, Smart-Halajko M, Bawazeer N, Al-Daghri NM, McTernan PG, Kumar S, Hitman GA, Saravanan P, Tripathi G. Vitamin B12 insufficiency induces cholesterol biosynthesis by limiting s-adenosylmethionine and modulating the methylation of SREBF1 and LDLR genes. Clinical Epigenetics, February 2015, 7(1), 14. PubMed PMID:25763114
40Quinlivan EP, Crider KS, Zhu JH, Maneval DR, Hao L, Li Z, Rasmussen SA, Berry RJ, Bailey LB. Hypomethylation of serum blood clot DNA, but not plasma EDTA-blood cell pellet DNA, from vitamin B12-deficient subjects. PLoS One, June 2013, 8(6), e65241. PubMed PMID:23785415
41Stabler SP, Allen RH, Dolce ET, Johnson MA. Elevated serum S-adenosylhomocysteine in cobalamin-deficient elderly and response to treatment. American journal of clinical nutrition, December 2006, 84(6), 1422-1429. PubMed PMID:17158426
42Stott DJ, MacIntosh G, Lowe GD, Rumley A, McMahon AD, Langhorne P, Tait RC, O'Reilly DS, Spilg EG, MacDonald JB, MacFarlane PW, Westendorp RG. Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients with vascular disease. American journal of clinical nutrition, December 2005, 82(6), 1320-1326. PubMed PMID: 16332666
B3 – Niacin (Nicotinamide) and Excessive Methylation Inhibition
Specific Indication: Assists in the reduction of excessive DNA methylation reactions.
Excessive methyl side effects may include:
Increased anxiety
Decrease in mood
Headaches or migraines
Muscle aches and pains
Rash
Nausea
Acne
insomnia
Pharmaceutical Effects: The randomized and single blinded clinical trial conducted by Premkumar et al.
from India in 2008 confirmed that 50 mg niacin (nicotinamide) intake daily can reduce excessive DNA
methylation in human patients effectively.1 No patient drop off or adverse effects were reported.
Clinical Benefits:
Reduces methylation reactions Eases side effects within hours No gluten, soy, corn, egg, dairy, GMO, fish, shellfish, nuts or prebiotics Vegan and vegetarian friendly
Another five clinical studies from Japan, China and the U.S. support the evidence that niacin (nicotinamide)
can reduce DNA methylation significantly in healthy humans, and humans with diseases.2-6 In addition, the
five studies in humans support the evidence that 50 to 100 milligram niacin (nicotinamide) oral intake daily
can effectively reduce excessive DNA methylation levels.
Warning: Any niacin may cause flushing. Flushing is caused by the activation of phospholipase A2, an
enzyme that stimulates the production of specific lipids called prostanoids. These molecules can induce
the dilation of blood vessels in the skin and trigger a flushing response. This flushing is not dangerous and
is no reason for alarm.
Figure 1. Dietary niacin inhibits DNA and other metabolite methylation.
http://www.nature.com/nchembio/journal/v9/n5/full/nchembio.1234.html?message-global=remove
References
1 Premkumar VG, Yuvaraj S, Shanthi P, & Sachdanandam P. Co-enzyme Q10, riboflavin and niacin supplementation on alteration of DNA repair enzyme and DNA methylation in breast cancer patients undergoing tamoxifen therapy. Br J Nutr. 2008 Dec; 100(6): 1179-82. PubMed PMID: 18377693 2Tian YJ, Li D, Ma Q, et al. Excess nicotinamide increases plasma serotonin and histamine levels. Sheng Li Xue Bao. 2013 Feb 25;65(1):33-8. PubMed PMID: 23426511. 3Sun WP, Li D, Lun YZ, et al. Excess nicotinamide inhibits methylation-mediated degradation of catecholamines in normotensives and hypertensives. Hypertension Research. 2012 Feb;35(2):180-5. PubMed PMID: 21918528. 4Aoyama K, Matsubara K, Okada K, et al. N-methylation ability for azaheterocyclic amines is higher in Parkinson's disease: nicotinamide loading test. Journal of Neural Transmission (Vienna). 2000;107(8-9):985-95. PubMed PMID: 11041277. 5Jacob RA, Pianalto FS, Henning SM, Zhang JZ, & Swendseid ME. In vivo methylation capacity is not impaired in healthy men during short-term dietary folate and methyl group restriction. Journal of Nutrition. 1995 Jun; 125(6): 1495-502. PubMed PMID: 7782903. 6Okada K., Matsubara K., Kobayashi S., et al. 275 Abnormal N-methylation of nicotinamide in Parkinson's disease.
Neurobiology of Aging, 1996,17(4), Supplement 1, S69.